Research

Items by Kinnunen, Hanne

Up a level
Export as [feed] RSS 1.0 [feed] Atom [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2015 | 2014 | 2012 | 2010
Number of items: 6.

2015

Kinnunen, H., Hebbink, G., Peters, H., Huck, D., Makein, L. and Price, R., 2015. Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition. International Journal of Pharmaceutics, 478 (1), pp. 53-59.

2014

Kinnunen, H., Hebbink, G., Peters, H., Shur, J. and Price, R., 2014. An Investigation into the Effect of Fine Lactose Particles on the Fluidization Behaviour and Aerosolization Performance of Carrier-Based Dry Powder Inhaler Formulations. AAPS PharmSciTech, 15 (4), pp. 898-909.

Kinnunen, H. M. and Mrsny, R. J., 2014. Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site. Journal of Controlled Release, 182 (1), pp. 22-32.

Kinnunen, H., Hebbink, G., Peters, H., Shur, J. and Price, R., 2014. Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks. AAPS PharmSciTech, 15 (4), pp. 1009-1020.

2012

Kinnunen, H., 2012. Active sites, agglomerates or increased cohesion? Investigations into the mechanism of how lactose fines improve dry powder inhaler performance. Thesis (Doctor of Philosophy (PhD)). University of Bath.

2010

Kinnunen, H., Shur, J., Hebbink, G., Muresan, A. S. and Price, R., 2010. Lactose fluidisation properties and their relationship to dry powder inhaler performance. Journal of Pharmacy and Pharmacology, 62 (10), pp. 1342-1343.

This list was generated on Sat Mar 28 22:18:24 2015 GMT.